atopic dermatitis

rocket launch satellite space fly blast off

Biotech

Amgen ignites Rocket program with wins in phase 3 eczema trials

The data provide more evidence rocatinlimab improves outcomes, but questions about the antibody's positioning versus Dupixent remain unanswered.

Nick Paul Taylor Mar 10, 2025 5:48am

team layoffs workforce

Q32 Bio sticks with bempikibart but lets go of staff

Feb 11, 2025 4:47am

Ikena, after tough year of layoffs, merges with Inmagene

Dec 23, 2024 10:00am

Person throwing piece of paper into full waste bin

Anaptys scraps atopic dermatitis asset after ph. 2 fail

Dec 11, 2024 11:02am

eczema atopic dermatitis Black African American patient skin of color

Q32's stock plunges in wake of anti-IL-7R antibody's eczema fail

Dec 11, 2024 8:25am

Man climbing up mountainside

Enveda envisions clinical wins with $130M series C raise

Nov 21, 2024 10:55am